{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:09:02Z","timestamp":1761822542177,"version":"3.30.2"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2003,6]]},"DOI":"10.1378\/chest.123.6.2150","type":"journal-article","created":{"date-parts":[[2003,6,14]],"date-time":"2003-06-14T00:09:19Z","timestamp":1055549359000},"page":"2150-2153","source":"Crossref","is-referenced-by-count":50,"title":["Methotrexate-Induced Pulmonary Lymphomaa"],"prefix":"10.1016","volume":"123","author":[{"given":"Celso T.","family":"Ebeo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirle R.","family":"Girish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryland P.","family":"Byrd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay B.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.123.6.2150_bib1","first-page":"259","article-title":"Paucity of radiographic progression in rheumatoid arthritis treated with methotrexate as the first disease modifying antirheumatic drug","volume":"26","author":"Rich","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1378\/chest.123.6.2150_bib2","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/art.1780280702","article-title":"Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis: a controlled clinical trial","volume":"28","author":"Williams","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.123.6.2150_bib3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0889-857X(21)00061-2","article-title":"Methotrexate: adverse reactions and major toxicities","volume":"20","author":"Goodman","year":"1994","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1378\/chest.123.6.2150_bib4","first-page":"912","article-title":"Methotrexate: the emerging drug of choice for serious rheumatoid arthritis","volume":"16","author":"Salach","year":"1994","journal-title":"Clin Ther"},{"key":"10.1378\/chest.123.6.2150_bib5","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/jama.1969.03150180053011","article-title":"Acute lymphocytic leukemia in children: maintenance therapy with methotrexate administered intermittently","volume":"207","author":"Acute Leukemia Group B","year":"1969","journal-title":"JAMA"},{"key":"10.1378\/chest.123.6.2150_bib6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/rheumatology\/35.5.441","article-title":"Occurrence of pulmonary complications during methotrexate therapy in rheumatoid arthritis","volume":"35","author":"Menkes","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1378\/chest.123.6.2150_bib7","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2165\/00002018-199920060-00002","article-title":"Lymphoma in patients with rheumatoid arthritis: what is the evidence of a link with methotrexate?","volume":"20","author":"Georgescu","year":"1999","journal-title":"Drug Saf"},{"key":"10.1378\/chest.123.6.2150_bib8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1164\/ajrccm.155.2.9032171","article-title":"Immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders","volume":"155","author":"Lynch","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.123.6.2150_bib9","series-title":"Pulmonary pathology","first-page":"511","article-title":"Iatrogenic and toxic injury","author":"Bedrosian","year":"1988"},{"key":"10.1378\/chest.123.6.2150_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0021-9681(86)90070-6","article-title":"Factors influencing mortality in rheumatoid arthritis","volume":"39","author":"Symmons","year":"1986","journal-title":"J Chronic Dis"},{"key":"10.1378\/chest.123.6.2150_bib11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/art.1780350202","article-title":"Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis: 84 month update","volume":"35","author":"Weinblatt","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.123.6.2150_bib12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0002-9343(85)90312-2","article-title":"Low-dose methotrexate treatment of rheumatoid arthritis: long-term observation","volume":"79","author":"Weinstein","year":"1985","journal-title":"Am J Med"},{"key":"10.1378\/chest.123.6.2150_bib13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1056\/NEJM198303033080901","article-title":"No increase in second tumors after cytotoxic chemotherapy for gestational trophoblastic tumors","volume":"308","author":"Rustin","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.123.6.2150_bib14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000249793","article-title":"Frequency of malignant neoplasm in 248 long-term methotrexate-treated psoriatics","volume":"167","author":"Nyfors","year":"1983","journal-title":"Dermatologica"},{"key":"10.1378\/chest.123.6.2150_bib15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/jnci\/65.4.801","article-title":"Role of natural killer cells in the destruction of circulating tumor emboli","volume":"65","author":"Hanna","year":"1980","journal-title":"J Natl Cancer Inst"},{"key":"10.1378\/chest.123.6.2150_bib16","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.4049\/jimmunol.127.5.1899","article-title":"Impaired regulation of Epstein-Barr virus induced lymphocyte proliferation in rheumatoid arthritis due to a T cell defect","volume":"127","author":"Depper","year":"1981","journal-title":"J Immunol"},{"key":"10.1378\/chest.123.6.2150_bib17","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/art.1780280902","article-title":"Different defects of T cell regulation of Epstein-Barr virus induced B cell activation in rheumatoid arthritis","volume":"28","author":"Kahan","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.123.6.2150_bib18","first-page":"665","article-title":"Epstein-Barr virus in rheumatoid arthritis","volume":"11","author":"Fox","year":"1985","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1378\/chest.123.6.2150_bib19","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/349612a0","article-title":"Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis [letter]","volume":"349","author":"Gregory","year":"1991","journal-title":"Nature"},{"key":"10.1378\/chest.123.6.2150_bib20","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0049-0172(97)80023-6","article-title":"Lymphoma in patients with rheumatoid arthritis: association with disease state or methotrexate treatment","volume":"26","author":"Georgescu","year":"1997","journal-title":"Semin Arthritis Rheum"},{"key":"10.1378\/chest.123.6.2150_bib21","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/jid.1962.160","article-title":"Oral methotrexate in mice: a co-carcinogenic as well as anti-tumor agent to methylcholanthrene-induced cutaneous tumors","volume":"39","author":"Barich","year":"1962","journal-title":"J Invest Dermatol"},{"issue":"Suppl IA","key":"10.1378\/chest.123.6.2150_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9343(85)90242-6","article-title":"Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland","volume":"78","author":"Hakulinen","year":"1985","journal-title":"Am J Med"},{"issue":"Suppl IA","key":"10.1378\/chest.123.6.2150_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0002-9343(85)90240-2","article-title":"Cancer and rheumatoid arthritis: epidemiologic considerations","volume":"78","author":"Prior","year":"1985","journal-title":"Am J Med"},{"issue":"Suppl A","key":"10.1378\/chest.123.6.2150_bib24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0896-8411(92)90055-U","article-title":"Malignancy in autoimmune disease","volume":"5","author":"Kinlen","year":"1992","journal-title":"J Autoimmun"},{"key":"10.1378\/chest.123.6.2150_bib25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0002-9343(99)80160-0","article-title":"Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: a retrospective study","volume":"99","author":"Moder","year":"1995","journal-title":"Am J Med"},{"issue":"Supp IA","key":"10.1378\/chest.123.6.2150_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0002-9343(85)90243-8","article-title":"Review of United States data on neoplasms in rheumatoid arthritis","volume":"78","author":"Castor","year":"1985","journal-title":"Am J Med"},{"key":"10.1378\/chest.123.6.2150_bib27","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/art.1780400906","article-title":"Rheumatoid arthritis and the risk of malignancy","volume":"40","author":"Cibere","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.123.6.2150_bib28","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199305063281806","article-title":"Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis","volume":"328","author":"Kamel","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.123.6.2150_bib29","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2133.1996.tb03621.x","article-title":"Reversible cutaneous lymphoma occurring during methotrexate therapy","volume":"135","author":"Viraben","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1378\/chest.123.6.2150_bib30","first-page":"1676","article-title":"A population based, case control study of non-Hodgkin\u2019s lymphoma in patients with rheumatoid arthritis","volume":"26","author":"Kamel","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1378\/chest.123.6.2150_bib31","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1200\/JCO.1996.14.6.1943","article-title":"Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases","volume":"14","author":"Salloum","year":"1996","journal-title":"J Clin Oncol"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216348474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216348474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T22:09:50Z","timestamp":1734041390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369216348474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["S0012369216348474"],"URL":"https:\/\/doi.org\/10.1378\/chest.123.6.2150","relation":{},"ISSN":["0012-3692"],"issn-type":[{"type":"print","value":"0012-3692"}],"subject":[],"published":{"date-parts":[[2003,6]]}}}